GFAP and ocular hypertension: Despite a prominent increase in the intensity and the coverage of GFAP immunolabeling with ocular hypertension, both of these imaging parameters were decreased (approximately 56% and 48%, respectively) in ocular hypertensive GFAP-IκKβ retinas relative to ocular hypertensive IκKβf/f controls.